Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
Authors:
Open Access
- 1 February 2008
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (2) , 331-338
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The use of intermediate purity factor VIII concentrate BPL 8Y as prophylaxis and treatment in congenital thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2006
- Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutationBlood, 2006
- Thrombotic thrombocytopenic purpuraJournal of Thrombosis and Haemostasis, 2005
- Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domainsGene, 2002
- Structure of von Willebrand Factor-cleaving Protease (ADAMTS13), a Metalloprotease Involved in Thrombotic Thrombocytopenic PurpuraJournal of Biological Chemistry, 2001
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- A Novel Human Metalloprotease Synthesized in the Liver and Secreted into the Blood: Possibly, the von Willebrand Factor--Cleaving Protease?The Journal of Biochemistry, 2001
- Partial amino acid sequence of purified von Willebrand factor–cleaving proteaseBlood, 2001
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.Proceedings of the National Academy of Sciences, 1990